145 related articles for article (PubMed ID: 7622309)
1. c-erbB growth-factor-receptor proteins in ovarian tumours.
Simpson BJ; Phillips HA; Lessells AM; Langdon SP; Miller WR
Int J Cancer; 1995 Jun; 64(3):202-6. PubMed ID: 7622309
[TBL] [Abstract][Full Text] [Related]
2. c-erbB-3 protein expression in ovarian tumours.
Simpson BJ; Weatherill J; Miller EP; Lessells AM; Langdon SP; Miller WR
Br J Cancer; 1995 Apr; 71(4):758-62. PubMed ID: 7710941
[TBL] [Abstract][Full Text] [Related]
3. Immunohistochemical localization of c-erbB-2 protein and epidermal growth factor receptor in normal surface epithelium, surface inclusion cysts, and common epithelial tumours of the ovary.
Wang DP; Konishi I; Koshiyama M; Nanbu Y; Iwai T; Nonogaki H; Mori T; Fujii S
Virchows Arch A Pathol Anat Histopathol; 1992; 421(5):393-400. PubMed ID: 1360720
[TBL] [Abstract][Full Text] [Related]
4. Expression of the ErbB family of receptors in ovarian cancer.
Scoccia B; Lee YM; Niederberger C; Ilekis JV
J Soc Gynecol Investig; 1998; 5(3):161-5. PubMed ID: 9614647
[TBL] [Abstract][Full Text] [Related]
5. Type 1 protein tyrosine kinases in benign and malignant breast lesions.
Suo Z; Emilsen E; Tveit KM; Nesland JM
Histopathology; 1998 Dec; 33(6):514-21. PubMed ID: 9870145
[TBL] [Abstract][Full Text] [Related]
6. Receptors for hormones and growth factors and (onco)-gene amplification in human ovarian cancer.
Berns EM; Klijn JG; Henzen-Logmans SC; Rodenburg CJ; van der Burg ME; Foekens JA
Int J Cancer; 1992 Sep; 52(2):218-24. PubMed ID: 1325950
[TBL] [Abstract][Full Text] [Related]
7. Expression of c-erbB-2, c-myc, and c-ras oncoproteins, insulin-like growth factor receptor I, and epidermal growth factor receptor in ovarian carcinoma.
van Dam PA; Vergote IB; Lowe DG; Watson JV; van Damme P; van der Auwera JC; Shepherd JH
J Clin Pathol; 1994 Oct; 47(10):914-9. PubMed ID: 7962604
[TBL] [Abstract][Full Text] [Related]
8. p53, c-erbB-2 and the epidermal growth factor receptor in the benign and malignant prostate.
Mellon K; Thompson S; Charlton RG; Marsh C; Robinson M; Lane DP; Harris AL; Horne CH; Neal DE
J Urol; 1992 Feb; 147(2):496-9. PubMed ID: 1370701
[TBL] [Abstract][Full Text] [Related]
9. The type 1 growth factor receptor family: new ligands and receptors and their role in breast cancer.
Gullick WJ; Srinivasan R
Breast Cancer Res Treat; 1998; 52(1-3):43-53. PubMed ID: 10066071
[TBL] [Abstract][Full Text] [Related]
10. C-erbB-3 in human breast carcinoma: expression and relation to prognosis and established prognostic indicators.
Travis A; Pinder SE; Robertson JF; Bell JA; Wencyk P; Gullick WJ; Nicholson RI; Poller DN; Blamey RW; Elston CW; Ellis IO
Br J Cancer; 1996 Jul; 74(2):229-33. PubMed ID: 8688326
[TBL] [Abstract][Full Text] [Related]
11. Frequent immunohistochemical detection of EGF supergene family members in ovarian carcinogenesis.
Stromberg K; Johnson GR; O'Connor DM; Sorensen CM; Gullick WJ; Kannan B
Int J Gynecol Pathol; 1994 Oct; 13(4):342-7. PubMed ID: 7814196
[TBL] [Abstract][Full Text] [Related]
12. Expression of growth factor receptors in human brain tumours.
Tuzi NL; Venter DJ; Kumar S; Staddon SL; Lemoine NR; Gullick WJ
Br J Cancer; 1991 Feb; 63(2):227-33. PubMed ID: 1671751
[TBL] [Abstract][Full Text] [Related]
13. Immunolocalization of epidermal growth factor receptor and c-erbB-2 oncogene product in human ovarian carcinoma.
Ito K; Sasano H; Ozawa N; Sato S; Silverberg SG; Yajima A
Int J Gynecol Pathol; 1992 Oct; 11(4):253-7. PubMed ID: 1356938
[TBL] [Abstract][Full Text] [Related]
14. Epidermal growth factor receptor and c-erbB-2 oncoproteins in tissue and tumor effusion cells of histopathologically different ovarian neoplasms.
Harlozińska A; Bar JK; Sobańska E; Goluda M
Tumour Biol; 1998; 19(5):364-73. PubMed ID: 9701727
[TBL] [Abstract][Full Text] [Related]
15. Expression of c-erbB-2 oncogene product in Barrett's adenocarcinoma: pathological and prognostic correlations.
Fléjou JF; Paraf F; Muzeau F; Fékété F; Hénin D; Jothy S; Potet F
J Clin Pathol; 1994 Jan; 47(1):23-6. PubMed ID: 7907608
[TBL] [Abstract][Full Text] [Related]
16. c-erbB-3 protein expression in human breast cancer: comparison with other tumour variables and survival.
Quinn CM; Ostrowski JL; Lane SA; Loney DP; Teasdale J; Benson FA
Histopathology; 1994 Sep; 25(3):247-52. PubMed ID: 7821892
[TBL] [Abstract][Full Text] [Related]
17. The prognostic value of epidermal growth factor receptors, determined by both immunohistochemistry and ligand binding assays, in primary epithelial ovarian cancer: a pilot study.
van der Burg ME; Henzen-Logmans SC; Foekens JA; Berns EM; Rodenburg CJ; van Putten WL; Klijn JG
Eur J Cancer; 1993; 29A(14):1951-7. PubMed ID: 8280488
[TBL] [Abstract][Full Text] [Related]
18. EGF-R and overexpression of the oncogene c-erbB-2 in ovarian cancer: immunohistochemical findings and prognostic value.
Meden H; Marx D; Raab T; Kron M; Schauer A; Kuhn W
J Obstet Gynaecol (Tokyo 1995); 1995 Apr; 21(2):167-78. PubMed ID: 8556578
[TBL] [Abstract][Full Text] [Related]
19. Immunohistochemical detection of TGF-alpha, EGF-R, c-erbB-2, c-H-ras, c-myc, estrogen and progesterone in benign and malignant human breast lesions: a concomitant expression.
Spaventi R; Kamenjicki E; Pecina N; Grazio S; Grazio S; Pavelic J; Kusic B; Cvrtila D; Danilovic Z; Spaventi S
In Vivo; 1994; 8(2):183-9. PubMed ID: 7919121
[TBL] [Abstract][Full Text] [Related]
20. Protein levels and gene expressions of the epidermal growth factor receptors, HER1, HER2, HER3 and HER4 in benign and malignant ovarian tumors.
Steffensen KD; Waldstrøm M; Andersen RF; Olsen DA; Jeppesen U; Knudsen HJ; Brandslund I; Jakobsen A
Int J Oncol; 2008 Jul; 33(1):195-204. PubMed ID: 18575766
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]